Phase II trial
If a pharmaceutical compound clears the phase I trial, investigators move on to phase II trials. At this stage, a few hundred patients are enrolled, and the researchers begin to look at safety as well as efficacy against a specific condition.
Phase II trials can take a year or two. Since phase II is measuring a potential drug against a specific condition, it's not unusual to see the same drug in multiple phase II studies, each looking at different endpoints. In the case of a cancer drug, for example, several trials may be ongoing on at the same time, testing it against different types of cancer.
Recent Mentions on Fool.com
- Opportunities in Lung Cancer Therapies
- FDA Approves New Alzheimer's Diagnostic Agent but Medicare and Markets Yet to Follow
- Raytheon Wins Contracts to Outfit Poseidons, Test Saudi Bombs, and Improve "LADAR"
- Is It Time to Go Long Sarepta Therapeutics?
- Why Anacor Pharmaceuticals Is Poised to Pull Back
- The Past, Present, and Future of Alzheimer?s Treatments